HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 32 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 53,501 | $42 | 0.00% |
| McAdam, LLC | 62,169 | $48,274 | 0.00% |
| Iron Gate Global Advisors LLC | 13,306 | $10,332 | 0.00% |
| Amplius Wealth Advisors, LLC | 10,000 | $7,765 | 0.00% |
| Capital Advisors, Ltd. LLC | 1 | $0 | 0.00% |
| NORTHERN TRUST CORP | 132,059 | $102,544 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 14,070 | $10,918 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31,535 | $24,487 | 0.00% |
| Cetera Investment Advisers | 19,746 | $15,333 | 0.00% |
| OSAIC HOLDINGS, INC. | 47,524 | $36,898 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 656,453 | $509,736 | 0.00% |
| BlackRock Inc. | 1,602,772 | $1,244,552 | 0.00% |
| Bank of New York Mellon Corp | 88,715 | $68,887 | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 156,909 | $121,840 | 0.00% |
| Citadel Advisors | 34,800 | $27,022 | 0.00% |
| Citadel Advisors | 1,648 | $1,280 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 1 | $0 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 37,000 | $28,860 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 154,754 | $120,166 | 0.00% |
External links
This page lists HEPION PHARMACEUTICALS INC's shareholders in Q1 2023. To view HEPION PHARMACEUTICALS INC's shareholder history, click here.